CRO Intel

Dashboard Companies Opportunity Signals Clinical Trials Hiring Intelligence Funding Publications FDA Settings

Company Intelligence

Discover companies with clinical, regulatory and hiring signals
Total Companies

6,643

Company Clinical Trials FDA Signals Hiring Opportunity Confidence Last Seen
Longbio Pharma (suzhou) — — —
60
36% 		7/17/2026 View Intelligence
Longboard Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Longstar Healthpro Dba Farlong Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Longwood Pharmaceuticals (hangzhou) — — —
60
36% 		7/17/2026 View Intelligence
Lophius Biosciences 3 trials — —
60
36% 		7/17/2026 View Intelligence
Lotus Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Lsk Global Pharma Services — — —
60
36% 		7/17/2026 View Intelligence
Ltn Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Ltz Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lucid Psycheceuticals (sub Of Fsd Pharma ) — — —
60
36% 		7/17/2026 View Intelligence
Lukare Medical — — —
60
40% 		7/20/2026 View Intelligence
Lumen Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lumena Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Luminary Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lumos Pharma — — —
60
36% 		7/17/2026 View Intelligence
Lumosa Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lunan Better Pharmaceutical — — —
60
36% 		7/17/2026 View Intelligence
Luoxin Aurovitas Pharma (Chengdu) — — —
60
39% 		7/20/2026 View Intelligence
Lupin Pharmaceuticals — — —
60
47% 		7/20/2026 View Intelligence
Lustre Pharmaceutical Lab — — —
60
36% 		7/17/2026 View Intelligence
Lutris Pharma — — —
60
36% 		7/17/2026 View Intelligence
Lux Biosciences — — —
60
36% 		7/17/2026 View Intelligence
Luxena Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Luye Pharma Group — — —
60
36% 		7/17/2026 View Intelligence
Lycia Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lyell Immunopharma 1 trials — —
60
36% 		7/17/2026 View Intelligence
Lyncbio Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lyne Laboratories — — —
60
39% 		7/20/2026 View Intelligence
Lynk Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Lyra Therapeutics — — —
60
36% 		7/17/2026 View Intelligence
Lyric Pharmaceuticals — — —
60
36% 		7/17/2026 View Intelligence
Lytix Biopharma As — — —
60
36% 		7/17/2026 View Intelligence
Lyvgen Biopharma Holdings — — —
60
36% 		7/17/2026 View Intelligence
M Et P Pharma — — —
60
36% 		7/17/2026 View Intelligence
M-star (Hubei) Health&Care Products — — —
60
40% 		7/20/2026 View Intelligence
MADE BY DENTISTS — — —
60
40% 		7/20/2026 View Intelligence
MADISON ONE ACME — — —
60
42% 		7/20/2026 View Intelligence
MAIA Pharmaceuticals — — —
60
40% 		7/20/2026 View Intelligence
MARKSANS PHARMA — — —
60
39% 		7/20/2026 View Intelligence
MATHESON TRI-GAS — — —
60
42% 		7/20/2026 View Intelligence
MDSolarSciences — — —
60
42% 		7/20/2026 View Intelligence
MEDRx USA — — —
60
40% 		7/20/2026 View Intelligence
MEGABABE — — —
60
40% 		7/20/2026 View Intelligence
METROPOLITANGRAPHIC ARTS — — —
60
40% 		7/20/2026 View Intelligence
MILLA PHARMACEUTICALS — — —
60
39% 		7/20/2026 View Intelligence
MING FAI ENTERPRISE (CAMBODIA) — — —
60
40% 		7/20/2026 View Intelligence
MIPS Cyclotron & Radiochemistry Facility — — —
60
39% 		7/20/2026 View Intelligence
MISOCOS — — —
60
40% 		7/20/2026 View Intelligence
MODULAR THERMAL TECHNOLOGIES DBA LIFE WEAR TECHNOLOGIES — — —
60
40% 		7/20/2026 View Intelligence
MPM Medical — — —
60
40% 		7/20/2026 View Intelligence
Showing 3501 - 3550 of 6,643 companies